niacin extended-release (NER)
Sponsors
Abbott
Conditions
Dyslipidemia
Phase 3
Study to Evaluate the EFFECTS of Acetylsalicylic Acid (ASA) on Niaspan®-Induced Flushing in Subjects With Dyslipidemia
CompletedNCT00626392
Start: 2008-02-29End: 2008-04-30Updated: 2009-09-02
Evaluation of a Flushing ASsessment Tool (FAST) in Subjects Receiving Niacin Extended-release Plus Aspirin
CompletedNCT00630877
Start: 2008-02-29End: 2008-06-30Updated: 2009-10-09